Endometrial hyperplasia happens when the lining of the uterus becomes thicker than usual, and it often causes abnormal uterine bleeding. Many people first hear about endometrial hyperplasia after bleeding between periods, very heavy periods, or bleeding after menopause. The early symptoms of endometrial hyperplasia can come on over weeks to months, and it is most often found in people around or after menopause, though it can also affect younger adults. Endometrial hyperplasia is usually not fatal, but some types can raise the risk of endometrial cancer if they are not treated. Treatment depends on the type and your plans for pregnancy, and it often includes progesterone therapy, follow-up sampling of the uterine lining, or sometimes surgery to remove the uterus.
How many people live with Endometrial hyperplasia?
There is no single, widely accepted estimate of how many people are living with endometrial hyperplasia worldwide or in the United States. Major public health sources do not regularly publish a global or U.S. total for this condition, and most research describes how often it is diagnosed rather than how many people are living with it at any one time.
Overview
Endometrial hyperplasiaSymptoms
Endometrial hyperplasia often causes abnormal uterine bleeding, such as very heavy periods, bleeding between periods, or bleeding after menopause. Some people also notice longer-lasting periods or pelvic cramping, though many have no other symptoms.
Outlook and prognosis
For many, endometrial hyperplasia improves with treatment and close follow-up, especially when found early. Outlook depends on the type: forms with atypical cells carry a higher risk of endometrial cancer and usually need more intensive care.
Causes and risk factors
Endometrial hyperplasia is usually driven by excess estrogen without enough progesterone. Risk rises with obesity, polycystic ovary syndrome, irregular periods, tamoxifen use, estrogen-only hormone therapy, and late menopause. Diabetes, never being pregnant, and inherited Lynch syndrome can also raise risk.
Genetic influences
Genetics usually play a limited role in endometrial hyperplasia. Most cases are linked more to hormone imbalance than inherited gene changes, though a family history of related cancers can sometimes matter. Genetic testing is not routinely needed for endometrial hyperplasia.
Diagnosis
Diagnosis of endometrial hyperplasia usually starts with a review of bleeding patterns, a pelvic exam, and ultrasound. It is confirmed with an endometrial biopsy.
Treatment and drugs
Endometrial hyperplasia is often treated with progesterone to thin the uterine lining. Some also need a procedure to remove tissue or a hysterectomy if changes are severe or keep returning. Regular follow-up biopsies are common.
Symptoms
Periods may become harder to predict, heavier than usual, or show up after months without bleeding. In endometrial hyperplasia, you might notice small changes at first, such as needing to change pads more often or seeing spotting between periods. The early symptoms of endometrial hyperplasia usually involve abnormal uterine bleeding, but some people have no symptoms at all. Bleeding after menopause is never considered normal and should be checked promptly.
Menstrual bleeding can be much heavier than usual and may include clots. Some people need to change pads or tampons more often or plan their day around the heaviest flow.
Bleeding may last longer than your usual period or continue for more days than expected. This can make it harder to know when one cycle has truly ended.
Periods may come closer together, skip for a while, or arrive at unexpected times. For many, this means the usual pattern of the menstrual cycle becomes hard to predict.
Light bleeding or brown spotting can happen between regular periods. Even small amounts can matter when they keep happening or are new for you.
How people usually first notice Endometrial hyperplasia?
Many people first notice endometrial hyperplasia when their bleeding pattern changes, especially periods that become heavier, last longer, come more often, or show up between periods. After menopause, even light vaginal bleeding or spotting can be an early warning sign, because bleeding at that stage is not expected and should be checked. Some people also notice cramping or pelvic discomfort, but for many, unusual uterine bleeding is the clearest first clue that the lining of the uterus has grown too thick.
Types of Endometrial hyperplasia
Endometrial hyperplasia can show up in everyday life as bleeding that feels off from your usual pattern, such as very heavy periods, bleeding between periods, or bleeding after menopause. Symptoms don’t always look the same for everyone. The main types of endometrial hyperplasia are based on whether the lining cells look abnormal under a microscope, and that difference matters because it affects cancer risk and treatment. In many living with endometrial hyperplasia, both types can cause similar bleeding symptoms, but one is usually more concerning than the other.
Non-atypical
This is the more common type, where the uterine lining is thicker than usual but the cells do not look clearly abnormal. Many people with non-atypical endometrial hyperplasia notice abnormal uterine bleeding, including heavy periods, spotting between periods, or bleeding after menopause. It often has a lower risk of turning into cancer than the atypical form.
Atypical
In this type, the lining is thickened and the cells look abnormal, which is why it is treated more urgently. Bleeding symptoms can look much like the early symptoms of endometrial hyperplasia in the non-atypical type, but bleeding may be more persistent or raise more concern, especially after menopause. This type, also called endometrial intraepithelial neoplasia in many medical settings, carries a higher risk of endometrial cancer.
Can I slow down the onset of symptoms?
Partly; there is good evidence that lowering long-term estrogen exposure without enough progesterone can reduce the chance of developing endometrial hyperplasia, but no lifestyle change is proven to prevent it or guarantee that symptoms will start later. The clearest modifiable factors are reaching a healthier weight if needed, staying physically active, managing problems that cause skipped or infrequent periods, and avoiding estrogen-only hormone therapy if you still have a uterus, because these steps may help keep the uterine lining from becoming too thick. If you have unusual bleeding, very spread-out periods, or need hormone treatment after menopause, early medical care matters because progesterone-based treatment is a well-established way to protect the lining and treat changes early, and while it cannot promise prevention, it can lower risk.
What genetics can tell you about symptoms
Genetics can sometimes help explain why endometrial hyperplasia develops and, in a smaller number of cases, why it may show up earlier or alongside a higher chance of progressing to endometrial cancer, especially when an inherited cancer syndrome runs in the family. For most people with endometrial hyperplasia, though, symptoms such as abnormal uterine bleeding are driven more by hormone exposure, age, body weight, and related health conditions than by a specific gene change. In other words, genetic testing is not usually used to predict day-to-day symptoms, but it can matter when the pattern is unusual, starts at a younger age, or there is a strong family history of uterine, colon, or related cancers.
Causes and risk factors
Endometrial hyperplasia usually happens when the lining of the uterus is exposed to too much estrogen and not enough progesterone. This is more likely when ovulation is irregular or stops, which can happen around menopause or with polycystic ovary syndrome. Common risk factors for endometrial hyperplasia include carrying extra body weight, diabetes, and estrogen-only hormone therapy. Tamoxifen, a medicine used for some breast cancers, can also increase the chance of endometrial hyperplasia in some people. Family history can be one part of the story, and inherited conditions such as Lynch syndrome can also raise risk.
What are the most common causes or risk factors?
Endometrial hyperplasia usually happens when the lining of the uterus is exposed to too much estrogen and not enough progesterone, so the lining keeps growing instead of shedding normally. The main risk factors are obesity, skipped or irregular periods because the body is not releasing an egg regularly, polycystic ovary syndrome (PCOS), the years around menopause, estrogen-only hormone therapy after menopause, and treatment with tamoxifen. An inherited tendency, especially a condition called Lynch syndrome or a strong family history of womb or colon cancer, can also raise risk, but most cases are linked to hormone imbalance rather than genetics.
Environmental and biological risk factors
Endometrial hyperplasia is more likely when the lining of the uterus is exposed to estrogen for too long without enough progesterone to balance it. Doctors often group risk factors for endometrial hyperplasia into internal (biological) and external (environmental). In everyday life, that usually means body changes or medicines that keep the lining growing instead of letting it shed in a regular way.
Taking estrogen without progesterone can overstimulate the uterine lining if the uterus is still present. The chance of endometrial hyperplasia usually rises with longer exposure or higher doses.
Tamoxifen is helpful for some breast conditions, but in the uterus it can act partly like estrogen. Over time, that can raise the risk of endometrial hyperplasia, especially after menopause.
When the body does not release an egg regularly, it may not make enough progesterone to balance estrogen. The lining can keep thickening instead of shedding in a predictable way. This pattern is common with polycystic ovary syndrome and some other hormone conditions.
In the years leading up to menopause, hormone levels can swing from month to month. Many cycles happen without egg release, which can make the uterine lining grow too much. After menopause, any source of extra estrogen matters more because monthly shedding has stopped.
Genetic risk factors
Most endometrial hyperplasia is not directly inherited, but a small number of people have genetic risks that make it more likely. It’s usually a combination of influences rather than one clear cause. The clearest inherited link is Lynch syndrome, and a strong family history of endometrial or colon cancer can be a clue that genetic risk factors for endometrial hyperplasia deserve a closer look.
Lynch syndrome: This inherited condition is the strongest well-known genetic risk for endometrial hyperplasia and endometrial cancer. It happens when a change in a DNA repair gene, such as MLH1, MSH2, MSH6, PMS2, or EPCAM, makes it easier for cells in the uterine lining to grow abnormally.
Family history: If several close relatives have had endometrial, colon, or related cancers, it can point to an inherited risk pattern in the family. This does not mean someone will definitely develop endometrial hyperplasia, but it can be a reason to ask about genetic counseling or testing.
PTEN changes: PTEN is a gene that helps put the brakes on cell growth, and changes in it are common in atypical endometrial hyperplasia, also called endometrial intraepithelial neoplasia. Most of these changes happen only in the uterine lining, but rare inherited PTEN-related syndromes can also raise risk.
Other cell changes: Some cases, especially the atypical form, also show gene changes such as PIK3CA, KRAS, CTNNB1, or ARID1A. These changes are usually not inherited, but they can help drive abnormal growth once the lining starts changing.
Lifestyle risk factors
Several everyday habits can change estrogen exposure, insulin resistance, and inflammation, which can influence the development and progression of endometrial hyperplasia. The most important lifestyle risk factors are excess body weight, low physical activity, and eating patterns that promote weight gain or poor metabolic health. Alcohol may also contribute by affecting hormone balance. Understanding lifestyle risk factors for endometrial hyperplasia can help lower the chance of worsening abnormal thickening of the uterine lining.
Carrying excess body fat can raise estrogen levels after menopause because fat tissue converts other hormones into estrogen. When estrogen is not balanced by progesterone, the endometrium is more likely to become overly thickened and develop hyperplasia.
Low activity levels make weight gain and insulin resistance more likely, both of which can increase the hormonal signals that stimulate the endometrium. Regular movement can help improve metabolic health and may reduce one of the key pathways that supports endometrial overgrowth.
A diet high in calories, refined carbohydrates, sugary drinks, and heavily processed foods can promote weight gain and worsen insulin resistance. Over time, this can increase estrogen-related stimulation of the uterine lining and raise the likelihood of endometrial hyperplasia progressing.
Drinking alcohol may increase circulating estrogen levels and can also make weight management harder. Higher intake may therefore add to hormone-related stimulation of the endometrium, especially in people who already have other metabolic risk factors.
Risk prevention
Endometrial hyperplasia is not always preventable, but many people can lower their risk by addressing hormone-related triggers and getting abnormal bleeding checked early. The biggest preventable risks are long-term exposure to estrogen without enough progesterone, excess body weight, and some medicines or health conditions that affect hormones. Prevention is about lowering risk, not eliminating it completely. If you are looking for ways to reduce the risk of endometrial hyperplasia, the main steps are tailored hormone care, weight management, and regular follow-up for unusual periods or bleeding after menopause.
Extra body fat can raise estrogen levels, which can overstimulate the lining of the uterus over time. Losing even a modest amount of weight, if recommended for you, may help lower the risk of endometrial hyperplasia.
If you still have a uterus and use estrogen therapy for menopause, adding progesterone is usually important to protect the uterine lining. A doctor can help choose the safest hormone plan based on your age, symptoms, and medical history.
Going many months without ovulating, which can happen with conditions like polycystic ovary syndrome, can leave the uterine lining exposed to unopposed estrogen. Regular cycles or prescribed progesterone treatment may help reduce that risk.
Tamoxifen can be an important breast cancer treatment, but it may increase the chance of changes in the uterine lining in some people. If you take it, report any unexpected vaginal bleeding promptly so problems can be checked early.
Can you prevent Endometrial hyperplasia?
You cannot always prevent endometrial hyperplasia, but some people can lower their risk. Risk may be lower if you stay in a weight range that is healthy for you, get help for very irregular or skipped periods, and review any menopause hormone treatment with your doctor so the lining of the womb is not exposed to estrogen alone. These steps do not guarantee prevention, but they can help reduce risk for some people.
Transmission
Many people ask whether endometrial hyperplasia is contagious, but it is not. Endometrial hyperplasia cannot be passed from one person to another through sex, kissing, blood, shared toilets, or everyday contact, and it is not considered infectious.
Instead, endometrial hyperplasia happens when the lining of the uterus grows too much, usually because of hormone imbalance rather than a virus or bacteria. For many living with endometrial hyperplasia, this means the focus is on finding the cause and getting the right follow-up care, not on avoiding contact with other people.
When to test your genes
Genetic testing is not routine for endometrial hyperplasia alone. It becomes worth discussing if hyperplasia is atypical, if you have endometrial cancer at a young age, or if your family history includes endometrial, colorectal, or ovarian cancer, because this can point to Lynch syndrome and help guide screening and treatment.
Diagnosis
Endometrial hyperplasia is usually checked because of abnormal uterine bleeding, such as very heavy periods, bleeding between periods, or bleeding after menopause. Doctors usually begin with your symptoms, age, menstrual pattern, medicines, and any factors that can raise estrogen levels, because these clues help show how likely the lining of the uterus is to be overgrowing. The diagnosis of endometrial hyperplasia is confirmed with tests that look at the uterine lining more closely.
A detailed family and health history can help doctors understand bleeding patterns, menopause status, and use of hormones such as estrogen or tamoxifen. This step also helps identify common causes of abnormal bleeding and who may need more testing.
A pelvic exam can help look for other causes of bleeding, including changes in the cervix, vagina, or uterus. It cannot confirm endometrial hyperplasia on its own, but it helps guide the next steps.
A transvaginal ultrasound uses a slim probe placed in the vagina to measure the thickness of the uterine lining and look for polyps or other changes. In many living with endometrial hyperplasia, this is one of the first imaging tests used.
This is the main test used to confirm endometrial hyperplasia. A small sample of the uterine lining is removed and examined under a microscope to see whether the cells are overgrown and whether any atypical, or abnormal, cells are present.
How is Endometrial hyperplasia diagnosed?
Endometrial hyperplasia is usually checked because of unusual uterine bleeding, such as very heavy periods, bleeding between periods, or bleeding after menopause. A doctor will ask about symptoms and health history and often do a pelvic exam and an ultrasound, usually with a small probe placed in the vagina, to see whether the lining of the uterus looks thicker than expected. The diagnosis is confirmed by taking a small sample of the uterine lining, called a biopsy, and looking at it under a microscope; genetic testing is not usually needed to diagnose it.
Stages of Endometrial hyperplasia
Endometrial hyperplasia does not have defined progression stages. That is because it is usually described by what the lining of the uterus looks like on testing, rather than by a steady step-by-step decline over time. Doctors usually start with a conversation about bleeding changes, since early symptoms of endometrial hyperplasia often include heavier periods, bleeding between periods, or bleeding after menopause. It is usually diagnosed and monitored with tests such as an ultrasound to look at the uterine lining and a sample of tissue from the uterus to check for abnormal cells.
Outlook and prognosis
The outlook for endometrial hyperplasia is generally good, especially when it is found early and treated appropriately. Prognosis depends mainly on whether atypia is present: hyperplasia without atypia often regresses with progestin therapy or removal of excess estrogen exposure, while atypical endometrial hyperplasia carries a substantially higher risk of progressing to endometrial cancer or already harboring an undiagnosed cancer at the time of diagnosis. With treatment and follow-up, many people do well and can prevent progression, although recurrence can occur if hormonal risk factors persist. Mortality from endometrial hyperplasia itself is low, but outcomes become more serious if it progresses to endometrial carcinoma. Regular surveillance with repeat sampling or definitive treatment such as hysterectomy, when indicated, is important for the best long-term outcome.
Long-term effects
For many people, the long-term effects of endometrial hyperplasia depend on the type of cell changes and whether treatment works. Some cases settle with treatment, while others can keep coming back or raise the risk of cancer over time. It is important to remember that long-term does not always mean progressive. One of the biggest questions is what happens if endometrial hyperplasia is left untreated, because ongoing abnormal cell growth can sometimes lead to more serious disease.
The most important long-term concern is a higher chance of endometrial cancer, especially when the cells look clearly abnormal under the microscope. This risk is much lower in forms without these atypical changes, but careful follow-up still matters.
Many living with endometrial hyperplasia continue to have irregular, heavy, or prolonged uterine bleeding over time. In day-to-day life, this can mean bleeding between periods, very heavy periods, or bleeding after menopause.
Repeated heavy bleeding can lower iron levels and lead to anemia. Over time, this may cause tiredness, shortness of breath with activity, dizziness, or feeling drained during normal routines.
Endometrial hyperplasia can make it harder to become pregnant because the lining of the uterus is not developing in a healthy way. Some may also need treatments that affect future fertility, depending on age, pregnancy goals, and biopsy results.
How is it to live with Endometrial hyperplasia?
Living with endometrial hyperplasia often means dealing with bleeding that feels unpredictable, heavier, or more frequent than usual, and that can ripple through daily life by draining energy, disrupting sleep, and making work, exercise, travel, or intimacy harder to plan. For many, the bigger burden is the uncertainty: waiting for test results, managing follow-up visits, and wondering whether the lining changes are simple overgrowth or a type that carries a higher risk of endometrial cancer. People around you may not see the condition itself, but partners, family, and close friends are often pulled into the practical and emotional side of it, helping with appointments, offering reassurance, and adjusting routines when symptoms flare.
Treatment and drugs
Treatment for endometrial hyperplasia depends on the type, how severe it is, whether abnormal cells are present, and whether you hope to become pregnant in the future. Many people with endometrial hyperplasia are treated with progesterone, a hormone that can help thin the uterine lining and may be given as pills, an intrauterine device, or sometimes injections. If first-line treatments don’t help, specialists may try second-line options, and when there is a higher risk of cancer or the condition keeps coming back, surgery to remove the uterus may be recommended. Alongside medical treatment, lifestyle choices play a role, especially if weight loss, better blood sugar control, or treatment for conditions like polycystic ovary syndrome can help lower extra estrogen exposure. Because the best treatment for endometrial hyperplasia varies from person to person, regular follow-up visits and repeat biopsies are often needed to check that the lining is improving.
Can you cure Endometrial hyperplasia?
Yes, many cases of endometrial hyperplasia can be treated successfully, and some can be reversed, especially when it is found early. Treatment often uses hormone medicine to thin the lining of the uterus and regular checkups to make sure it is improving. If the cells look abnormal or the condition is severe, surgery to remove the uterus may be the most effective way to prevent it from turning into cancer.
Non-drug treatment
Day-to-day care for endometrial hyperplasia often involves more than medicine alone. Non-drug treatments may help lower extra estrogen exposure, improve overall health, and in some cases remove abnormal tissue or the uterus itself. Managing this condition often means matching treatment to the biopsy result, whether you still want pregnancy, and whether other health issues such as obesity, diabetes, or polycystic ovary syndrome are present.
If you are overweight, losing even a modest amount of weight can help reduce estrogen made by body fat and may lower the chance that the lining keeps thickening. For many, this is part of treatment for endometrial hyperplasia without atypia, especially when weight gain is a major driver.
Regular physical activity can support weight loss, improve insulin resistance, and help with related conditions that raise risk. Simple routines—like walking or cycling—can have lasting benefits when they become part of everyday life.
Eating in a way that supports a healthy weight can be useful, especially if large swings in blood sugar or overeating are part of the picture. A dietitian can help build a plan that feels realistic rather than overly strict.
A careful review of hormone therapy can be important if unopposed estrogen is contributing to the problem. Some may need changes to menopausal hormone therapy or a discussion about whether estrogen-containing treatments are still appropriate.
Your genes may have an impact on how drugs work for you
For people with endometrial hyperplasia, treatment often uses hormone medicine called progestin, and people do not all respond to it in the same way. Small inherited differences in how the body processes medicines and how the uterine lining responds to hormones may affect how well treatment works or what side effects show up, but this is not something doctors routinely test for in everyday care. In practice, care is usually guided more by follow-up biopsies, bleeding patterns, age, and pregnancy plans than by genetic testing.
Pharmacological treatments
Treatment for Endometrial hyperplasia often focuses on medicines that add back progesterone, the hormone that helps counterbalance estrogen and can thin the uterine lining over time. The main drug options are progestin treatments, given either through an intrauterine device or by mouth, and the best choice depends on whether atypical cells are present, whether pregnancy is desired, and how heavy the bleeding has been. Not everyone responds to the same medication in the same way.
A levonorgestrel-releasing intrauterine device is often one of the most effective medicines for Endometrial hyperplasia, especially when doctors want strong treatment inside the uterus with less medicine circulating through the whole body. It can reduce bleeding and help the lining return to normal, and it is commonly used in fertility-sparing treatment for endometrial hyperplasia.
Medroxyprogesterone acetate and megestrol acetate are commonly used oral progestin medicines for Endometrial hyperplasia. They work by slowing and reversing overgrowth of the uterine lining, but they may cause side effects such as bloating, breast tenderness, headaches, or mood changes.
Micronized progesterone or norethindrone may be used in some cases, especially for people with non-atypical Endometrial hyperplasia or when a different progestin is better tolerated. These options are generally less established than levonorgestrel IUD treatment or the more commonly used oral progestins, but they can still be appropriate for selected people.
Combined birth control pills are sometimes used when Endometrial hyperplasia is linked to irregular ovulation, especially in younger people who also want cycle control and contraception. They are not the usual first choice for atypical hyperplasia, but they may help protect the lining in carefully selected non-atypical cases.
Genetic influences
If you are wondering whether endometrial hyperplasia is hereditary, the answer is that most cases are not caused by a single inherited gene. It’s natural to ask whether family history plays a role. For many people with endometrial hyperplasia, hormone imbalance, especially ongoing estrogen without enough progesterone, matters more than genetics. Still, some inherited conditions, most notably Lynch syndrome and rarer PTEN-related syndromes, can raise the chance of abnormal changes in the lining of the uterus and increase the risk of endometrial cancer. If endometrial hyperplasia happens at a younger age or there is a strong family history of uterine, colon, or related cancers, doctors may suggest genetic counseling and sometimes genetic testing. Knowing this history can help guide follow-up and treatment, but it does not mean you will definitely develop the condition.
Is Endometrial hyperplasia genetic?
Genetics usually play a limited role in endometrial hyperplasia. Most cases are linked more to hormone imbalance than inherited gene changes, though a family history of related cancers can sometimes matter. Genetic testing is not routinely needed for endometrial hyperplasia.
Having a genetic risk is not necessarily a diagnosis
Changes in genes, called genetic variants, are a usual part of human biology and are found in many people. Most of these variants do not directly affect health and simply reflect normal human diversity. For many genes, having a variant connected with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-studied variant in a specific gene may be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When treatment for endometrial hyperplasia seems to vary from one person to another, it is usually because doctors are balancing biopsy results, cancer risk, and future pregnancy plans. Many people wonder why the same medication works well for one person but not for another. For endometrial hyperplasia, the main medicine is progesterone-based treatment, but there is not yet a standard genetic test that reliably tells doctors which drug or dose will work best. Instead, genetics matters more when someone has an inherited condition such as Lynch syndrome, which raises the risk that endometrial hyperplasia could progress to endometrial cancer and may lead to closer follow-up or surgery rather than medication alone. Scientists are also studying whether differences in genes involved in hormone signaling and drug breakdown help explain why progesterone treatment for endometrial hyperplasia works better for some people, but this is not routine care yet. For now, treatment is guided mainly by the biopsy findings, age, menopause status, other health conditions, and whether preserving fertility is important.
Interactions with other conditions
Many living with endometrial hyperplasia also have other health issues that affect hormone balance, especially obesity, polycystic ovary syndrome, and diabetes. These conditions can raise estrogen exposure or make periods less regular, which may keep the uterine lining growing when it should be shedding. Day-to-day, it can feel like one health issue amplifies the other, such as when irregular bleeding becomes harder to sort out in someone already dealing with PCOS or heavy periods. Endometrial hyperplasia also matters because some forms, especially those with abnormal cells, are more closely linked with endometrial cancer, so doctors may watch these changes more carefully. Less often, a strong family history of uterine or colon cancer can point to an inherited cancer syndrome, which may change how endometrial hyperplasia is evaluated and followed. If you are worried about the early symptoms of endometrial hyperplasia or how it fits with another condition, it helps to discuss the full picture with your doctor so treatment can address all the factors involved.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Endometrial hyperplasia?
Heavy or irregular bleeding like the kind seen with endometrial hyperplasia can also happen with uterine fibroids, uterine polyps, and hormone-related problems such as polycystic ovary syndrome or the hormone changes that can happen around menopause. Adenomyosis, a condition where the lining tissue grows into the muscle of the womb, can cause similar bleeding and cramping too. In some cases, cancer of the lining of the womb can look similar, which is why unusual bleeding should always be checked by a doctor.
History
Long before modern scans and lab testing, doctors were already describing cases of unusual thickening of the lining of the uterus, now called endometrial hyperplasia. In older records, this was usually recognized through day-to-day problems such as heavy periods, bleeding between periods, or bleeding after menopause rather than through a clear understanding of what was happening in the tissue itself. For many living with endometrial hyperplasia, that history still matters, because the condition has long been tied to symptoms that can disrupt work, sleep, and daily routines.
As pathology developed in the 19th and 20th centuries, doctors began examining uterine tissue under the microscope and separating different kinds of lining changes that had once been grouped together. This helped them see that some forms of endometrial hyperplasia were mild and less likely to cause serious problems, while others carried a higher risk of later turning into endometrial cancer. In recent decades, awareness has grown as researchers refined these categories and worked to make diagnosis more consistent, so treatment could better match the level of risk.
Over time, the history of endometrial hyperplasia has also been shaped by a better understanding of hormones. Doctors learned that the condition often develops when the lining of the uterus is exposed to estrogen without enough balancing progesterone, which helped explain why it can appear around menopause, with irregular ovulation, or during certain hormone treatments. Researchers later identified a genetic side to how some cancers develop from abnormal lining cells, but the main shift in everyday care came from earlier recognition, biopsy testing, and closer follow-up.
That change has made a real difference. Someone who once might have been told only that they had “abnormal bleeding” is now more likely to have the cause checked sooner and described more clearly. Knowing the history of endometrial hyperplasia also helps explain why doctors take early symptoms of endometrial hyperplasia seriously: the goal is not to alarm people, but to catch concerning changes early and treat them before they progress.